Overview

Influence of Nevirapine on HCV Viral Load

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Nevirapine-based antiretroviral therapy is associated with lower plasma HCV viral load in HIV/HCV-coinfected individuals.
Phase:
N/A
Details
Lead Sponsor:
Valme University Hospital
Collaborator:
Boehringer Ingelheim
Treatments:
Efavirenz
HIV Protease Inhibitors
Nevirapine
Protease Inhibitors